Aspen Pharmacare
(OTC) APNHY
Aspen Pharmacare Financials at a Glance
Market Cap
$3.39B
Revenue (TTM)
$83.20B
Net Income (TTM)
$2.41B
EPS (TTM)
$-0.23
P/E Ratio
-32.52
Dividend
$0.12
Beta (Volatility)
0.35 (Low)
Dividend
$0.12
Beta (Volatility)
0.35 (Low)
Price
$7.63
Volume
63
Open
$7.63
Price
$7.63
Volume
63
Open
$7.63
Previous Close
$7.63
Daily Range
$7.63 - $7.63
52-Week Range
$5.24 - $9.08
Dividend
$0.12
Beta (Volatility)
0.35 (Low)
Price
$7.63
Volume
63
Open
$7.63
Previous Close
$7.63
Daily Range
$7.63 - $7.63
52-Week Range
$5.24 - $9.08
APNHY News
APNHY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aspen Pharmacare
Industry
Pharmaceuticals
Sector
Health CareEmployees
9,557
CEO
Stephen Bradley Saad, PhD
Website
www.aspenpharma.comHeadquarters
Durban, ZA
APNHY Financials
Key Financial Metrics (TTM)
Gross Margin
42%
Operating Margin
16%
Net Income Margin
-5%
Return on Equity
-3%
Return on Capital
5%
Return on Assets
-2%
Earnings Yield
-3.08%
Dividend Yield
0.02%
Payout Ratio
-47.07%
Stock Overview
Market Cap
$3.39B
Shares Outstanding
444.02M
Volume
63
Short Interest
0.00%
Avg. Volume
605.328
Financials (TTM)
Gross Profit
$19.13B
Operating Income
$1.44B
EBITDA
$2.16B
Operating Cash Flow
$5.16B
Capital Expenditure
$5.05B
Free Cash Flow
$104.00M
Cash & ST Invst.
$6.41B
Total Debt
$36.12B
Aspen Pharmacare Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.27B
-23.0%
Gross Profit
$7.10B
-23.8%
Gross Margin
43.64%
N/A
Market Cap
$3.39B
N/A
Market Cap/Employee
$382.08K
N/A
Employees
8,867
N/A
Net Income
$1.40B
-39.4%
EBITDA
$3.87B
-12.9%
Quarterly Fundamentals
Net Cash
$27.30B
-11.3%
Accounts Receivable
$562.45M
-38.0%
Inventory
$15.44B
-18.5%
Long Term Debt
$29.31B
+19.5%
Short Term Debt
$3.60B
-68.9%
Return on Assets
-1.56%
N/A
Return on Invested Capital
5.49%
N/A
Free Cash Flow
$2.33B
+141.5%
Operating Cash Flow
$3.41B
+38.6%